drugset / Trial / NCT01922687

Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

NCT01922687

Phase 4 Unknown 109 enrolled Shanghai Institute of Hypertension
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to test the hypothesis that amlodipine plus atorvastatin given in a single tablet (Caduet), compared with amlodipine alone (Norvasc), has a stronger effect in protection of arterial structure and function.

Timeline

Start
2011-04
Primary completion
2014-03
Completion
2014-12

Publications

  • Background Pingjin Gao

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified
Subject Atorvastatin Small molecule

Indications